Protein kinase C and preconditioning: Role of the sarcoplasmic reticulum

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Yamamura, Ken ^a   Steenbergen, Charles ^b   Murphy, Elizabeth ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1,2 dioctanoyl sn glycerol; Calcium; Protein kinase C ; Protein phosphatase 1

Indexed keywords

CAFFEINE; CALCIUM ION; DIOCTANOIN; FURA 2; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE C; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; SERINE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; CELL HYPOXIA; ISCHEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCYTES, CARDIAC; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM;

EID: 28144458325     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00590.2005     Document Type: Article

References (42)

1. Armstrong SC, Liu GS, Downey JM, and Ganote CE. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol 27: 1765-1774, 1995.
2. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, and Ping P. Protein kinase C-ε interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92: 873-880, 2003.
3. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, and Ping P. Mitochondrial PKC-ε and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKC-ε-MAPK interactions and differential MAPK activation in PKC-ε-induced cardioprotection. Circ Res 90: 390-397, 2002.
4. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, and Molkentin JD. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat Med 10: 248-254, 2004.
5. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E, and Solaro RJ. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 278: 11265-11272, 2003.
6. 2+ in adult rat cardiac myocytes. Circ Res 66: 1143-1155, 1990.
7. Cave AC and Garlick PB. Is a functional sarcoplasmic reticulum necessary for preconditioning? J Mol Cell Cardiol 32: 415-427, 2000.
8. 19F nuclear magnetic resonance study. Circ Res 83: 898-907, 1998.
9. Chen W, Wetsel W, Steenbergen C, and Murphy E. Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. J Mol Cell Cardiol 28: 871-880, 1996.
10. 16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β-agonists. J Biol Chem 275: 38938-38943, 2000.
11. + production. J Mol Cell Cardiol 34: 361-367, 2002.
12. Doble BW, Ping P, Fandrich RR, Cattini PA, and Kardami E. Protein kinase C-ε mediates phorbol ester-induced phosphorylation of connexin-43. Cell Commun Adhes 8: 253-256, 2001.
13. Dorn GW II, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, and Mochly-Rosen D. Sustained in vivo cardiac protection by a rationally designed peptide that causes ε-protein kinase C translocation. Proc Natl Acad Sci USA 96: 12798-12803, 1999.
14. 2+ ATPase pump of sarcoplasmic reticulum attenuate reperfusion stunning in isolated rat heart. J Cardiovasc Pharmacol 24: 678-684, 1994.
15. Edes I and Kranias EG. Phospholamban and troponin I are substrates for protein kinase C in vitro but not in intact beating guinea pig hearts. Circ Res 67: 394-400, 1990.
16. Forbes RA, Steenbergen C, and Murphy E. Diazoxide-induced cardio-protection requires signaling through a redox-sensitive mechanism. Circ Res 88: 802-809, 2001.
17. Gray MO, Karliner JS, and Mochly-Rosen D. A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 272: 30945-30951, 1997.
18. Han R and Bakker AJ. The effect of chelerythrine on depolarization- induced force responses in skinned fast skeletal muscle fibres of the rat. Br J Pharmacol 138: 417-426, 2003.
19. Inagaki K, Begley R, Ikeno F, and Mochly-Rosen D. Cardioprotection by ε-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an ε-protein kinase C-activating peptide. Circulation 111: 44-50, 2005.
20. Johnson JA, Gray MO, Chen CH, and Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271: 24962-24966, 1996.
21. Koss KL and Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. Circ Res 79: 1059-1063, 1996.
22. 2+ cycling. Am J Physiol Heart Circ Physiol 271: H643-H650, 1996.
23. Liu GS, Cohen MV, Mochly-Rosen D, and Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31: 1937-1948, 1999.
24. Liu Y, Ytrehus K, and Downey JM. Evidence that translocation of protein kinase C is a key event during ischemie preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668, 1994.
25. MacDougall LK, Jones LR, and Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 196: 725-734, 1991.
26. 2+ release. Circ Res 92: 904-911, 2003.
27. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, and Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76: 73-81, 1995.
28. 2+ movement. Basic Res Cardiol 97, Suppl I: 191-195, 2002.
29. Nicolas JM, Renard-Rooney DC, and Thomas AP. Tonic regulation of excitation-contraction coupling by basal protein kinase C activity in isolated cardiac myocytes. J Mol Cell Cardiol 30: 2591-2604, 1998.
30. Osada M, Netticadan T, Tamura K, and Dhalla NS. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning. Am J Physiol Heart Circ Physiol 274: H2025-H2034, 1998.
31. Pi Y, Sreekumar R, Huang X, and Walker JW. Positive inotropy mediated by diacylglycerol in rat ventricular myocytes. Circ Res 81: 92-100, 1997.
32. Ping P, Song C, Zhang J, Guo Y, Cao X, Li RC, Wu W, Vondriska TM, Pass JM, Tang XL, Pierce WM, and Bolli R. Formation of protein kinase Cε-Lck signaling modules confers cardioprotection. J Clin Invest 109: 499-507, 2002.
33. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, and Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
34. Piper HM, Abdallah Y, and Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61: 365-371, 2004.
35. Puceat M and Brown JH. Protein Kinase C in the Heart. New York: Oxford University Press, 1994.
36. 2+ accumulation in cardiac sarcoplasmic reticulum. J Biol Chem 265: 4302-4308, 1990.
37. + channels by protein kinase C. Circ Res 83: 110-114, 1998.
38. Speechly-Dick ME, Mocanu MM, and Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590, 1994.
39. 2+ release from sarcoplasmic reticulum of rat heart. Am J Physiol Heart Circ Physiol 271: H876-H881, 1996.
40. Ytrehus K, Liu Y, and Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol Heart Circ Physiol 266: H1145-H1152, 1994.
41. 2+ channels. A possible mechanism of ischemic preconditioning. Circ Res 76: 1049-1056, 1995.
42. Zucchi R, Ronca F, and Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther 89: 47-65, 2001.